IFNG and malignant colon neoplasm: To determine the effect of IFNG and its inhibitor glucosamine on the chemosensitivity of cisplatin in colon cancer, combined with the IC50 of cisplatin (25μmol/L), we examined the survival of cisplatin resistant DLD-1 after treatment with IFNG or glucosamine.